TrialTranslational psychiatry2019

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.

Kasper Recourt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.